The abstract is read at the publisher; the summary is JClub's.
BNIP3 is downregulated in acute necrotizing pancreatitis and its restoration via AAV-PAN-Bnip3 gene therapy promotes mitophagy, reducing pancreatic necrosis and systemic inflammation in mouse models.
- Why it matters: Mitochondrial dysfunction in pancreatic acinar cells is an early event in ANP, but how mitophagy is regulated and whether it can be therapeutically targeted remained unclear.
- What they did: The study assessed BNIP3 expression in ANP patients, tested BNIP3-mediated mitophagy in pancreatic tissue from ANP mouse models, and used AAV-PAN-Bnip3 to restore BNIP3; it also mapped FOXA2 as a direct upstream regulator of the Bnip3 promoter.
- The result: BNIP3-dependent mitophagy limited mitochondrial dysfunction and oxidative stress by preventing cytosolic mtDNA release, suppressing AIM2 inflammasome activation and acinar cell pyroptosis; pancreas-specific FOXA2 overexpression activated BNIP3 and conferred protection.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.